SCI时时刷

search
Digenic Alport Syndrome
Digenic Alport Syndrome
IntroductionAlport syndrome (OMIM #301050) is the second most common cause of genetic kidney failure after polycystic kidn...
Longitudinal Evaluation of Donor-Derived Cellfree DNA in Pediatric Kidney Transplantation
Longitudinal Evaluation of Donor-Derived Cellfree DNA in Pediatric Kidney Transplantation
Visual AbstractAbstractBackground and objectives Donor-derived cellfree DNA (cfDNA) is a less-invasive marker of allograft...
"Make Me a Match": All-In and Other Trends in the Nephrology Match
"Make Me a Match": All-In and Other Trends in the Nephrology Match
Nephrology entered the National Resident Matching Program (NRMP) Medical Specialties Matching Program (MSMP) in 2009 to im...
How I Treat Steroid-Sensitive Nephrotic Syndrome in Children
How I Treat Steroid-Sensitive Nephrotic Syndrome in Children
IntroductionSteroid-sensitive nephrotic syndrome represents the most frequent pediatric glomerular disease (1), persisting...
Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN Study
Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN Study
Visual AbstractAbstractBackground and objectives In the BLISS-LN study, belimumab improved kidney outcomes in adult patien...
Acute Kidney Injury in Patients with Liver Disease
Acute Kidney Injury in Patients with Liver Disease
AbstractAKI is commonly encountered in patients with decompensated cirrhosis, and it is associated with unfavorable outcom...
Integrating PROMs in Routine Dialysis Care: The Devil Is in the (Implementation) Details
Integrating PROMs in Routine Dialysis Care: The Devil Is in the (Implementation) Details
Steps for Creating an Account: Click the "Purchase Access" button.  The page will redisplay with the following messa...
The Role of Anti-B Cell Activating Factor Therapy for Treating Lupus Nephritis
The Role of Anti-B Cell Activating Factor Therapy for Treating Lupus Nephritis
Steps for Creating an Account: Click the "Purchase Access" button.  The page will redisplay with the following messa...
Can We Turn the Symptom Curve?: Symptom Trajectories and Outcomes among Patients with CKD
Can We Turn the Symptom Curve?: Symptom Trajectories and Outcomes among Patients with CKD
Steps for Creating an Account: Click the "Purchase Access" button.  The page will redisplay with the following messa...
Genome-Wide Association Study for eGFR in a Taiwanese Population
Genome-Wide Association Study for eGFR in a Taiwanese Population
Visual AbstractAbstractBackground and objectives Chronic kidney disease (CKD) is a global public health issue associated w...
Five-Year Symptom Trajectories in Nondialysis-Dependent CKD Patients
Five-Year Symptom Trajectories in Nondialysis-Dependent CKD Patients
Steps for Creating an Account: Click the "Purchase Access" button.  The page will redisplay with the following messa...
Reducing the Risks of Home Dialysis Innovation and Uptake: The Case for Human-Centered Product Design
Reducing the Risks of Home Dialysis Innovation and Uptake: The Case for Human-Centered Product Design
“A disruptive innovation is a technologically simple innovation in the form of a product, service, or business model that ...
Toxic Occupational Exposures and Membranous Nephropathy
Toxic Occupational Exposures and Membranous Nephropathy
Visual AbstractAbstractBackground and objectives Membranous nephropathy is a rare autoimmune kidney disease whose increasi...
Gut Microbiome and Kidney Disease: Reconciling Optimism and Skepticism
Gut Microbiome and Kidney Disease: Reconciling Optimism and Skepticism
The Microbiome HypeIntegrative analyses of metagenomics, metatranscriptomics, metaproteomics, and metabolomics have provid...
Correction: Physiology of the Aging Kidney: We Know Where We Are Going, but We Dont Know How...
Correction: Physiology of the Aging Kidney: We Know Where We Are Going, but We Dont Know How...
Delanaye P, Pottel H, Melsom T: Physiology of the aging kidney: We know where we are going, but we don’t know how… Clin J ...
Employment Status and Work Functioning among Kidney Transplant Recipients
Employment Status and Work Functioning among Kidney Transplant Recipients
Visual AbstractAbstractBackground and objectives To date, employment figures of kidney transplant recipients in Europe are...
Reducing Racial Disparities in Access to Transplant in the United States: One Step at a Time
Reducing Racial Disparities in Access to Transplant in the United States: One Step at a Time
Steps for Creating an Account: Click the "Purchase Access" button.  The page will redisplay with the following messa...
Genome-Wide Epistatic Interaction between DEF1B and APOL1 High-Risk Genotypes for Chronic Kidney Disease
Genome-Wide Epistatic Interaction between DEF1B and APOL1 High-Risk Genotypes for Chronic Kidney Disease
CKD disproportionately affects Black and Hispanic/Latino individuals. APOL1 risk variants are common in individuals of rec...
Associations of COVID-19 Outcomes with Dialysis Modalities and Settings
Associations of COVID-19 Outcomes with Dialysis Modalities and Settings
AbstractHow maintenance dialysis modality, dialysis setting, and residence in a nursing facility have jointly associated w...
Postoperative Acute Kidney Injury
Postoperative Acute Kidney Injury
AbstractPostoperative AKI is a common complication of major surgery and is associated with significant morbidity and morta...
Drug Development for Cystic Kidney Diseases
Drug Development for Cystic Kidney Diseases
Inherited cystic diseases include a spectrum of disorders, such as autosomal dominant polycystic kidney disease (ADPKD), a...
Rituximab in the Frail and Elderly with Severe ANCA-Associated GN
Rituximab in the Frail and Elderly with Severe ANCA-Associated GN
Steps for Creating an Account: Click the "Purchase Access" button.  The page will redisplay with the following messa...
Perspectives on Drug Development in Early ADPKD
Perspectives on Drug Development in Early ADPKD
IntroductionThe Critical Path Institute’s Polycystic Disease Outcomes Consortium, including key stakeholders (patients, me...
Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney Disease
Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney Disease
IntroductionAutosomal recessive polycystic kidney disease (ARPKD) is a rare hepatorenal fibrocystic disease that often pre...